Arabinogalatan Boosts Digestive Competence

Byron's Comments:

There are two types of arabinogalactan product. This first part of this abstract refers to the digestive fiber product we use in Fiber helper, LeptiFiber, and Daily Protein Plus-Vanialla, the second part relates to the specially filtered immune boosting product that is contain in Immune Plus and Super Immune Booster. It contains different molecular weights, which is why it is different from the basic fiber product (and more expensive).

Study Title:

Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide.

Study Abstract:

Larch arabinogalactan is composed of greater than 98-percent arabinogalactan, a highly branched polysaccharide consisting of a galactan backbone with side-chains of galactose and arabinose sugars. Larch arabinogalactan is an excellent source of dietary fiber, and has been approved as such by the FDA. It has been shown to increase the production of short-chain fatty acids, principally butyrate and propionate, and has been shown to decrease the generation and absorption of ammonia. Evidence also indicates human consumption of larch arabinogalactan has a significant effect on enhancing beneficial gut microflora, specifically increasing anaerobes such as Bifidobacteria and Lactobacillus. Larch arabinogalactan has several interesting properties which appear to make it an ideal adjunctive supplement to consider in cancer protocols. Experimental studies have indicated larch arabinogalactan can stimulate natural killer (NK) cell cytotoxicity, enhance other functional aspects of the immune system, and inhibit the metastasis of tumor cells to the liver. The immune-enhancing properties also suggest an array of clinical uses, both in preventive medicine, due to its ability to build a more responsive immune system, and in clinical medicine, as a therapeutic agent in conditions associated with lowered immune function, decreased NK activity, or chronic viral infection.

Study Information:

Kelly GS. Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Altern Med Rev. 1999 December 4(2):96-103.

Full Study:

http://www.thorne.com/media/larch_arabinogalactan.pdf

Related Entries: New Insights on Tinnitus